Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2019) 67 O25 | DOI: 10.1530/endoabs.67.O25

EYES2019 7th ESE Young Endocrinologists and Scientists (EYES) Meeting Oral Presentations (67 abstracts)

Evaluation of microRNA in patients with obesity: association with coronary artery disease

Teona A Shvangiradze , Irina Z Bondarenko & Ekatreina A Troshina


Endocrinology Research Centre, Moscow, Russia.


Introduction: Recent studies claim that microRNAs (miRNAs) participate in the pathogenesis of coronary artery disease (CAD).

Objective: To study miRNA expression in patients with obesity, determine their association with CAD.

Methods: MiRNAs were detected in peripheral blood. 66 patients with BMI 30.0–39.9 kg/m2 were divided into 3 groups: 1st – with CAD and T2DM, 2nd – with T2DM and excluded CAD, 3rd – with obesity and excluded CAD and T2DM. For miRNA profiling, the RT-qPCR assay was performed.

Results: Expression of miRNA-21 (P=0.0004), miRNA-26a (P=0.003), miRNA-33a (P=0.009) was different in the studied groups, while miRNA-1 (P=0.065) did not show significant difference. MiRNA-21 correlated with HbA1c (r=–0.360; P=0.001); cholesterol (r=–0.222; P=0.048) and with the thickness of interventricular septum (r=–0.397; P=0.0002) and posterior wall of the left ventricle (r=–0.382; P=0.0005). In the 2nd group miRNA-21 correlated with cholesterol (r=–0.425; P=0.048) and HDL (r=–0.498; P=0.018). MiRNA-1 correlated with cholesterol (r=0.255; P=0.023); LDL-cholesterol (r=0.292; P=0.009); HbA1c (r=0.297; P=0.007) and with the thickness of interventricular septum (r=0.338; P=0.002) and posterior wall of the left ventricle (r=0.409; P=0.009); and ejection fraction (r=–0.241; P=0.032). MiRNA-33a correlated with brachiocephalic arteries stenosis (r=0.453; P=0.039). In the 3rd group, miRNA-33a correlated with cholesterol (r=–0.419; P=0.046). In the 1st group miRNA-26a correlated with LDL-cholesterol (r=0.541; P=0.011) and waist circumference (r=0.481; P=0.027).

Conclusions: Expression of miRNA-21, miRNA-26a and miRNA-33a differ in patients with obesity. MiRNA-1, miRNA-21 and miRNA33a were associated with heart remodeling processes and may determine the severity of CAD.

Volume 67

7th ESE Young Endocrinologists and Scientists (EYES) Meeting

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.